<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://pharmadog.xyz/news/690747</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T19:59:14.000Z</news:publication_date>
      <news:title>Federal judge blocks Trump administration&apos;s visa length limits for foreign graduate students and postdocs</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/690703</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T19:17:34.000Z</news:publication_date>
      <news:title>AstraZeneca and Alexion receive FDA nod for Klygefa, a weekly self-administered myasthenia gravis therapy</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/690579</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T18:54:06.000Z</news:publication_date>
      <news:title>FDA proposes new classification that formally recognizes NAC as a dietary ingredient, ending its legal gray area</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/690535</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T18:30:34.000Z</news:publication_date>
      <news:title>Helus Pharma reports Phase 3 depression trial shows symptom improvement but safety concerns linger</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/690580</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T18:18:25.000Z</news:publication_date>
      <news:title>Expert warns that newer obesity GLP-1 drugs could spark access battles in low-income nations</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/134233</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T18:05:00.000Z</news:publication_date>
      <news:title>CLINUVEL to cut up to 20% of staff and move headquarters to New York</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/690411</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T17:47:11.000Z</news:publication_date>
      <news:title>John Powers III named permanent director of NIAID after year-long vacancy</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/690431</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T17:14:00.000Z</news:publication_date>
      <news:title>FDA rejects Summit Therapeutics&apos; ivonescimab combo, citing lack of survival benefit in lung cancer</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/690432</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T17:00:00.000Z</news:publication_date>
      <news:title>CG Oncology’s cretostimogene cuts bladder cancer recurrence risk by 68% in Phase 3 trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/690433</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T16:57:00.000Z</news:publication_date>
      <news:title>J&amp;J to acquire Ollin Biosciences for up to $3.3 billion, adding eye disease drug to its portfolio</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/690243</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T16:56:33.000Z</news:publication_date>
      <news:title>Biotech sector rebounds but gains are uneven, with Chinese firms and a large Sofinnova fund leading the surge</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/690244</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T16:52:09.000Z</news:publication_date>
      <news:title>Health-care providers turn to lawsuits over unpaid services as insurance costs squeeze paychecks</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/690199</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T16:19:12.000Z</news:publication_date>
      <news:title>China adds CAR-T therapy to national insurance list, slashing price to $40,000</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/690031</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T15:57:41.000Z</news:publication_date>
      <news:title>Parker Institute CEO Karen Knudsen says cancer research faces translation challenges</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/690055</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T15:50:46.000Z</news:publication_date>
      <news:title>Helus Pharma’s Phase 3 trial shows strong depression benefit but safety concerns emerge</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/690056</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T15:21:03.000Z</news:publication_date>
      <news:title>J&amp;J buys Ollin Biosciences for $2.2 billion, taps Blackstone for $750 million Phase 3 eye drug funding</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/690057</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T15:13:51.000Z</news:publication_date>
      <news:title>Eli Lilly to acquire Calytrix Bio for up to $1.5 billion to add blood-cancer assets</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/690058</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T14:58:12.000Z</news:publication_date>
      <news:title>FDA issues CRL for Summit Therapeutics&apos; ivonescimab, underscoring need for overall survival data</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/689887</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T14:53:32.000Z</news:publication_date>
      <news:title>Novo’s CagriSema shows over 20% weight loss at low doses in Phase 3 trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/689888</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T14:39:13.000Z</news:publication_date>
      <news:title>Canadian biotech firms turn to Europe as US political uncertainty creates new market opportunities</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/689863</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T14:37:18.000Z</news:publication_date>
      <news:title>Eli Lilly makes 14th acquisition of 2026, buying a blood-cancer biotech</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/689889</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T14:35:21.000Z</news:publication_date>
      <news:title>Wave Life Sciences reports stronger weight-loss effect of WVE-007 in patients with higher BMI and excess body fat</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/689907</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T14:17:01.000Z</news:publication_date>
      <news:title>CDC finds 10% of U.S. adults used GLP-1 drugs in 2025, 20% of them took compounded versions; Russia may seize foreign drug IP</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/689739</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T13:37:10.000Z</news:publication_date>
      <news:title>Democrats adopt &quot;Medicare for More&quot; as new health-care expansion message</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/689740</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T13:07:47.000Z</news:publication_date>
      <news:title>STAT+: Helus’ psychedelic drug improved depression in study but faces safety questions</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/689527</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T13:00:01.000Z</news:publication_date>
      <news:title>CG Oncology&apos;s oncolytic therapy shows positive Phase 3 results in non-muscle invasive bladder cancer</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/689741</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T13:00:00.000Z</news:publication_date>
      <news:title>CG Oncology&apos;s bladder cancer immunotherapy cuts tumor recurrence risk by 68% in study</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/689719</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T12:55:35.000Z</news:publication_date>
      <news:title>IQVIA report finds 90% of drugs launched 2016-2020 unlikely to recoup costs</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/689759</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T12:44:00.000Z</news:publication_date>
      <news:title>Eli Lilly to acquire Calytrix Bio for up to $1.5B, targeting rare blood cancers</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/689528</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T12:04:27.000Z</news:publication_date>
      <news:title>Flagship Pioneering invests £100 million to launch AI-focused biotech lab in London</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/689295</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T11:00:00.000Z</news:publication_date>
      <news:title>VC John Doerr praises Tom Health AI tool as promising solution for primary care</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/690678</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T10:40:00.000Z</news:publication_date>
      <news:title>CG Oncology reports 68% drop in bladder cancer recurrence in phase 3 trial of cretostimogene</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/688981</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T10:00:00.000Z</news:publication_date>
      <news:title>Clinical AI pilots stall due to organizational environment, not technology</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/688979</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T10:00:00.000Z</news:publication_date>
      <news:title>Seawolf Therapeutics raises $100M and secures up to $1.2B partnership with Sanofi</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/689107</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T10:00:00.000Z</news:publication_date>
      <news:title>Seawolf Therapeutics raises $100M and secures up to $1.2B partnership with Sanofi for redosable DNA medicines</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/689127</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T10:00:00.000Z</news:publication_date>
      <news:title>Versant and Eli Lilly commit $100 million to launch Seawolf Therapeutics, a non-viral gene-therapy startup</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/688980</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T10:00:00.000Z</news:publication_date>
      <news:title>New polymer lidding technologies aim to make pharmaceutical blister packs fully recyclable</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/688982</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T10:00:00.000Z</news:publication_date>
      <news:title>Choosing the Right AI Infrastructure Is Key to Accelerating Future Drug Discoveries</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/689083</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T10:00:00.000Z</news:publication_date>
      <news:title>San Diego’s Seawolf Therapeutics raises $100M to develop non-viral gene therapies for obesity, muscle loss and osteoporosis</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/690007</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T09:41:00.000Z</news:publication_date>
      <news:title>Biogen signs $411 million deal with TrimTech to develop protein degraders for neurodegenerative diseases</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/690006</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T09:37:00.000Z</news:publication_date>
      <news:title>Helus Pharma&apos;s modified psilocybin meets primary and secondary goals in phase 3 depression trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/688959</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T09:30:00.000Z</news:publication_date>
      <news:title>Kennedy&apos;s MAHA Initiative Gains Momentum with Stephen Miller as White House Chief of Staff</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/688960</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T09:30:00.000Z</news:publication_date>
      <news:title>Proposal to start medical school after Step 1 exam to cut debt and boost diversity</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/688961</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T09:30:00.000Z</news:publication_date>
      <news:title>AAMC leadership stays vigilant after midterm shift, urges continued congressional support for research</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/688963</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T09:30:00.000Z</news:publication_date>
      <news:title>Physician burnout persists as hospitals push self-care instead of systemic fixes</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/688962</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T09:30:00.000Z</news:publication_date>
      <news:title>BeOne Medicines and Hengrui Lead STAT-WireScreen’s China Biotech Powerhouse 25 Ranking</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/689839</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T09:23:00.000Z</news:publication_date>
      <news:title>J&amp;J to acquire Ollin Biosciences for $2.2 billion to advance bispecific eye drug OLN324 against Roche’s Vabysmo</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/689838</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T09:03:00.000Z</news:publication_date>
      <news:title>Eli Lilly acquires Calytrix Bio in $1.5 billion deal to add myelofibrosis antibody to its pipeline</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/689670</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T07:57:00.000Z</news:publication_date>
      <news:title>Aclaris Therapeutics’ bosakitug fails Phase 2 eczema trial, TSLP program dropped</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/688579</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T07:00:17.000Z</news:publication_date>
      <news:title>Sofinnova Partners raises €725 million for second crossover fund targeting late-stage European biotech firms</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/688643</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T07:00:00.000Z</news:publication_date>
      <news:title>Sofinnova Partners raises €725M crossover fund to back later-stage European biotech firms</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/689334</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T06:10:00.000Z</news:publication_date>
      <news:title>Flagship Pioneering invests £100 million to launch AI-focused biotech incubation lab in London</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/688267</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T05:25:00.000Z</news:publication_date>
      <news:title>Emerging biotech hubs like India could help lower global drug costs by scaling development</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/688268</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T05:24:00.000Z</news:publication_date>
      <news:title>BridgeBio&apos;s Morgan Paull and Christine Zhang Named BioSpace 40 Under 40, Emphasize Patient-Centric Model</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/688269</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T05:02:00.000Z</news:publication_date>
      <news:title>Biopharma firms showcase non-amyloid Alzheimer’s strategies at CTAD 2026 conference</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/688270</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T05:01:00.000Z</news:publication_date>
      <news:title>Novartis and BMS pause autoimmune CAR-T trials after patient deaths and safety concerns</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/688890</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T03:47:00.000Z</news:publication_date>
      <news:title>Chinese authorities dismiss two researchers after child dies in gene‑editing study</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/688554</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T02:32:00.000Z</news:publication_date>
      <news:title>Tandem Diabetes Care gets FDA clearance for tubeless insulin delivery system with up to 7-day wear</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/687527</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:25:43.000Z</news:publication_date>
      <news:title>Apple and OpenEvidence Begin Study of Experimental AI Health Chat App</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/685563</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-15T14:03:30.000Z</news:publication_date>
      <news:title>FDA denies Summit Therapeutics&apos; ivonescimab for EGFR-mutated lung cancer, halting US entry</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/685095</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-15T12:56:23.000Z</news:publication_date>
      <news:title>FDA rejects Summit and Akeso&apos;s ivonescimab for narrow lung cancer</news:title>
    </news:news>
  </url>
</urlset>
